您的位置: 首页 > 农业专利 > 详情页

Compound inhibiting activities of btk and/or jak3 kinases
专利权人:
BEIJING HANMI PHARMACEUTICAL CO. LTD.
发明人:
Liu Jinming,Cha Mi Young,Li Gong,Li Zhanmei,Qiu Hongjuan,Kim Maengsup
申请号:
NZ71872814
公开号:
NZ718728A
申请日:
2014.09.18
申请国别(地区):
NZ
年份:
2017
代理人:
摘要:
The present invention relates to a compound inhibiting the activities of Bruton’s tyrosine kinase (BTK) and/or Janus kinase 3 (JAK3), a pharmaceutical composition of the compound, pharmaceutical applications of same, a method for using the compound in inhibiting the activities of BTK and/or JAK3, and a method for using the compound in treatment and/or prevention of BTK- and/or JAK3-mediated diseases or disorders in mammals (especially human). The compound is as represented by structural formula (I).
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充